Use of


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 21 12 2022
accepted: 13 02 2023
entrez: 20 3 2023
pubmed: 21 3 2023
medline: 22 3 2023
Statut: epublish

Résumé

Upper respiratory tract infections (URTI) are the most common illnesses affecting athletes, causing absences from training and competition. Salivary immunoglobulin A (sIgA) is the main immune factor in saliva, and a consistent association between low concentrations of sIgA and an increased incidence of URTIs has been reported. The oral probiotic Active young students were randomised into a treated group ( Twenty (M = 14, F = 6) young subjects (23.5 ± 2.3 years old) participated in the study. The total accumulated training load (sRPE) in the supplementation period was similar in the two groups (treated: 4345 ± 3441 AU; control: 4969 ± 4165 AU; p > 0.05). Considering both sIgA level and secretion rate, significant time (F This study demonstrates that relatively short-term

Identifiants

pubmed: 36936914
doi: 10.3389/fimmu.2023.1129060
pmc: PMC10019894
doi:

Substances chimiques

Immunoglobulin A, Secretory 0

Types de publication

Randomized Controlled Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1129060

Informations de copyright

Copyright © 2023 Bertuccioli, Gervasi, Annibalini, Binato, Perroni, Rocchi, Sisti and Amatori.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor FDP declared a past collaboration with the author AB.

Références

Med Sci Sports Exerc. 2008 Jul;40(7):1228-36
pubmed: 18580401
Br J Sports Med. 2022 Jun;56(11):639-650
pubmed: 35277393
Eur J Immunol. 2020 Jun;50(6):783-794
pubmed: 32065660
Microbiol Rev. 1995 Jun;59(2):171-200
pubmed: 7603408
Appl Physiol Nutr Metab. 2016 Jan;41(1):96-102
pubmed: 26701121
AMB Express. 2021 Mar 6;11(1):41
pubmed: 33677720
Nat Commun. 2021 Mar 30;12(1):1961
pubmed: 33785765
Oral Dis. 2005;11 Suppl 1:29-31
pubmed: 15752094
BMC Microbiol. 2016 Sep 29;16(1):225
pubmed: 27681377
Nat Rev Immunol. 2017 Jan;17(1):21-29
pubmed: 27916977
Int J Sports Med. 2000 May;21(4):302-7
pubmed: 10853703
Cell Rep. 2019 Jul 2;28(1):245-256.e4
pubmed: 31269444
J Dent. 2005 Mar;33(3):223-33
pubmed: 15725522
Microorganisms. 2022 Sep 28;10(10):
pubmed: 36296202
Biology (Basel). 2021 Apr 23;10(5):
pubmed: 33922542
Sports Med. 2002;32(1):53-73
pubmed: 11772161
Front Bioeng Biotechnol. 2021 Jun 24;9:646184
pubmed: 34249878
Immunol Cell Biol. 2000 Oct;78(5):496-501
pubmed: 11050532
Nutrients. 2022 Mar 07;14(5):
pubmed: 35268099
Eur Rev Med Pharmacol Sci. 2016 Nov;20(21):4601-4606
pubmed: 27874935
PLoS One. 2016 Sep 22;11(9):e0163389
pubmed: 27657502
Drug Healthc Patient Saf. 2014 Feb 13;6:15-20
pubmed: 24600248
J Sports Sci. 1999 Feb;17(2):129-34
pubmed: 10069269
Neuroimmunomodulation. 2020;27(1):75-78
pubmed: 32506067
Oral Microbiol Immunol. 2007 Apr;22(2):126-30
pubmed: 17311636
Int J Sports Med. 2006 Nov;27(11):849-55
pubmed: 16586343
Exerc Immunol Rev. 2020;26:8-22
pubmed: 32139352
Front Nutr. 2022 May 10;9:900448
pubmed: 35634421
Pflugers Arch. 2022 Dec;474(12):1221-1248
pubmed: 36251066
Indian J Pediatr. 2001 Jul;68 Suppl 3:S46-50
pubmed: 11980459
Med Sci Sports Exerc. 2005 Mar;37(3):374-80
pubmed: 15741834
Expert Opin Biol Ther. 2013 Mar;13(3):339-43
pubmed: 23286823
Int J Sports Med. 1994 Oct;15 Suppl 3:S131-41
pubmed: 7883395
Drug Healthc Patient Saf. 2016 Nov 21;8:77-81
pubmed: 27920580
J Athl Train. 1997 Oct;32(4):344-9
pubmed: 16558471
Sports Med. 2007;37(4-5):416-9
pubmed: 17465623
Nat Microbiol. 2020 Jul;5(7):878-880
pubmed: 32393856
Sports Med. 1995 Jun;19(6):393-400
pubmed: 7676100
Infect Immun. 2015 Sep;83(9):3438-44
pubmed: 26077762
Clin Sports Med. 2007 Jul;26(3):311-9
pubmed: 17826186
Front Physiol. 2017 Jul 11;8:485
pubmed: 28744226
Eur J Clin Microbiol Infect Dis. 2008 Dec;27(12):1261-3
pubmed: 18560907
Appl Environ Microbiol. 2010 Jun;76(12):3948-58
pubmed: 20418429
Minerva Pediatr. 2018 Jun;70(3):240-245
pubmed: 29322750
Res Sports Med. 2015;23(2):140-50
pubmed: 25639912
Int J Environ Res Public Health. 2022 Feb 08;19(3):
pubmed: 35162910
J Sports Sci. 2021 Jan;39(1):101-107
pubmed: 32842905
Front Immunol. 2018 Apr 16;9:648
pubmed: 29713319
Int J Sports Med. 1994 Oct;15 Suppl 3:S116-21
pubmed: 7883392
Front Microbiol. 2022 Apr 29;13:895537
pubmed: 35572634
Appl Environ Microbiol. 2007 Feb;73(4):1107-13
pubmed: 17194838
Biology (Basel). 2021 Sep 03;10(9):
pubmed: 34571745
Indian J Med Res. 2004 May;119 Suppl:13-6
pubmed: 15232154
J Clin Epidemiol. 2005 Jun;58(6):609-17
pubmed: 15878475
J Strength Cond Res. 2001 Feb;15(1):109-15
pubmed: 11708692
Int J Gen Med. 2012;5:991-7
pubmed: 23233809
J Appl Microbiol. 2006 Apr;100(4):754-64
pubmed: 16553730
Physiol Rev. 2000 Jul;80(3):1055-81
pubmed: 10893431
Ther Clin Risk Manag. 2016 Jan 19;12:87-92
pubmed: 26855579

Auteurs

Alexander Bertuccioli (A)

Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.

Marco Gervasi (M)

Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.

Giosuè Annibalini (G)

Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.

Beatrice Binato (B)

Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.

Fabrizio Perroni (F)

Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.

Marco B L Rocchi (MBL)

Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.

Davide Sisti (D)

Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.

Stefano Amatori (S)

Department of Biomolecular Sciences, University of Urbino Carlo Bo, Urbino, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH